Skip to main content
SpringerLink
Log in

Hypoglycemia in Type 1 Diabetes

  • Chapter
Type 1 Diabetes

Part of the book series: Contemporary Endocrinology ((COE))

  • 554 Accesses

Abstract

Although the introduction of insulin therapy was life-saving for patients with type 1 diabetes, problems of iatrogenic hypoglycemia were noticeable from the outset.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Banting FG, Campbell WR, Fletcher AA. Further clinical experience with insulin (pancreatic extracts) in the treatment of diabetes mellitus. Br Med J 1923;1:8–12.

    Article  PubMed  CAS  Google Scholar 

  2. Pramming S, Thorsteinsson B, Bendtson I, Binder C. The relationship between symptomatic and biochemical hypoglycaemia in insulin-dependent diabetic patients. J Intern Med 1990;228:641–646.

    Article  PubMed  CAS  Google Scholar 

  3. Field JB. Hypoglycemia. Definition, clinical presentations, classification, and laboratory tests. Endocrinol Metab Clin North Am 1989;18:27–43.

    PubMed  CAS  Google Scholar 

  4. Marks V. The measurement of blood glucose and the definition of hypoglycemia. Horm Metab Res 1976;6(Suppl): 1–6.

    PubMed  CAS  Google Scholar 

  5. Deary IJ, Hepburn DA, MacLeod KM, Frier BM. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis. Diabetologia 1993;36:771–777.

    Article  PubMed  CAS  Google Scholar 

  6. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271–286.

    Article  Google Scholar 

  7. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med 1991;8:217–222.

    Article  PubMed  CAS  Google Scholar 

  8. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulintreated diabetic patients. Diabet Med 1993;10:238–245.

    Article  PubMed  CAS  Google Scholar 

  9. Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994;17:697–703.

    Article  PubMed  CAS  Google Scholar 

  10. Goldstein D, England J, Hess R, Rawlings S, Walker B. A prospective study of symptomatic hypoglycemia in young diabetic patients. Diabetes Care 1981;4:601–605.

    Article  PubMed  CAS  Google Scholar 

  11. The Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125:177–188.

    Article  Google Scholar 

  12. Mortensen HB, Hougaard P, for the Hvidore Study Group on Childhood Diabetes. Comparison of metabolic control in a cross-sectional study of 2873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714–720.

    Article  PubMed  CAS  Google Scholar 

  13. Davis EA, Keating B, Byrne GC, Russell, Jones TW. Impact of improved glycaemic control on rates of hypoglycaemia in IDDM. Arch Dis Child 1998;78:111–115.

    Article  PubMed  CAS  Google Scholar 

  14. Gale EAM, Tatersall RB. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics. Lancet 1979; i:1049–1052.

    Article  Google Scholar 

  15. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C. Nocturnal hypoglycaemia in patients receiving treatment with insulin. Br Med J 1985;291:376–379.

    Article  CAS  Google Scholar 

  16. Bendtson I, Gade J, Rosenfalck AM, Thomsen CE, Wildschiodtz G, Binder C. Nocturnal EEG registration in type 1 (insulin-dependent) patients with hypoglycemia. Diabetologia 1991;34:750–756.

    Google Scholar 

  17. George E, Bedford C, Peacey SR, Hardisty CA, Heller SR. Further evidence for a high incidence of nocturnal hypoglycaemia in IDDM: no effect of dose for dose transfer between human and porcine insulins. Diabet Med 1997;14:442–448.

    Article  PubMed  CAS  Google Scholar 

  18. Whincup G, Milner RDG. Prediction and management of nocturnal hypoglycaemia in diabetes. Arch Dis Child 1987;62:333–337.

    Article  PubMed  CAS  Google Scholar 

  19. Beregszaszi M, Tubiana-Rufi N, Benali K, Noel M, Bloch J, Czernichow P. Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: Prevalence and risk factors. J Pediatr 1997;131:27–33.

    Article  PubMed  CAS  Google Scholar 

  20. Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediatr 1997;130:366–372.

    Article  PubMed  CAS  Google Scholar 

  21. Lopez MJ, Oyarzabal M, Barrio R, Hermoso F, Lopez JP, Rodriguez M, et al. Nocturnal hypoglycaemia in IDDM patients younger than 18 years. Diabet Med 1997;14:772–777.

    Article  PubMed  CAS  Google Scholar 

  22. Matyka KA, Wiggs L, Pramming S, Stores G, Dunger DB. Cognitive function and mood following profound nocturnal hypoglycaemia during conventional therapy of diabetes. Arch Dis Child 1999;81: 138–142.

    Article  PubMed  CAS  Google Scholar 

  23. Meyer C, Dostou JM, Gerich J. Role of the human kidney in glucose counterregulation. Diabetes 1999;48:943–948.

    Article  PubMed  CAS  Google Scholar 

  24. Stumvoll M, Chintalapudi U, Periello G, Gutierrez O, Gerich J. Uptake and release of glucose by the human kidney: postabsorptive rates and responses to epinephrine. J Clin Invest 1995;96:2528–2533.

    Article  PubMed  CAS  Google Scholar 

  25. Cersosimo E, Judd RL, Miles JM. Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 1994;93:2584–2589.

    Article  PubMed  CAS  Google Scholar 

  26. Joseph SE, Heaton N, Potter D, Pernet A, Umpleby MA, Amiel SA. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes 2000;49:450–456.

    Article  PubMed  CAS  Google Scholar 

  27. Taborsky GJ, Ahren B, Havel PJ. Autonomic mediation of glucagon secretion during hypoglycemia. Implications for impaired α-cell responses in type 1 diabetes. Diabetes 1998;47:995–1005.

    Article  PubMed  CAS  Google Scholar 

  28. Landstedt-Hallin L, Adamson U, Lins PE. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab 1999;84:3140–3145.

    Article  PubMed  CAS  Google Scholar 

  29. Egger M, Gschwend S, Smith GD, Zuppinger K. Increasing incidence of hypoglycemic coma in children with IDDM. Diabetes Care 1991;14:1001–1005.

    Article  PubMed  CAS  Google Scholar 

  30. Mathias CJ, Frankel HL, Turner RC, Christensen NJ. Physiological responses to insulin hypoglycaemia in spinal man. Paraplegia 1979;17:319–326.

    Article  PubMed  CAS  Google Scholar 

  31. Frizzell RT, Campbell PJ, Cherrington AD. Gluconeogenesis and hypoglycemia. Diabetes Metab Rev 1988;4:51–70.

    Article  PubMed  CAS  Google Scholar 

  32. Cryer PE. Catecholamines, pheochromocytoma, and diabetes. Diabetes Rev 1993;1:309–317.

    Google Scholar 

  33. Clutter WE, Rizza RA, Gerich JE, Cryer PE. Regulation of glucose metabolism by sympathochromaffin catecholamines. Diabetes Metab Rev 1988;4:1–15.

    Article  PubMed  CAS  Google Scholar 

  34. Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR. Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J 1990;301:783–787.

    Article  CAS  Google Scholar 

  35. Thompson CJ, Bayliss PH. Endocrine changes during insulin-induced hypoglycaemia. In: Frier B, and Fisher BM, eds. Hypoglycaemia in Clinical Diabetes. Edward Arnold, London 1993, pp. 116–132.

    Google Scholar 

  36. Blackgard WG, Hiedingsfelder SA. Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest 1968;47:1407–1414.

    Article  Google Scholar 

  37. Tatar P, Vigas M. Role of α1- and α2-adrenergic receptors in the growth hormone and prolactin response to insulin-induced hypoglycemia in man. Neuroendocrinology 1984;39:275–280.

    Article  PubMed  CAS  Google Scholar 

  38. Evans PJ, Dieguez C, Foord SM, Peters JR, Hall R, Scanlon MF. The effect of cholinergic blockade on the growth hormone and prolactin response to insulin hypoglycaemia. Clin Endocrinol 1985;22:733–737.

    Article  CAS  Google Scholar 

  39. Cordido F, Dieguez C, Casanueva FF. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine or hypoglycaemia in normal and obese subjects. J Clin Endocrinol Metab 1990;70:1361–1370.

    Article  PubMed  CAS  Google Scholar 

  40. Metcalfe P, Johnston DG, Nosadini R, Orksov H, Alberti KGMM. Metabolic effects of acute and prolonged growth hormone excess in normal and insulin deficient man. Diabetologia 1981;20:123–128.

    Article  PubMed  CAS  Google Scholar 

  41. Bratush-Marrain PR, Smith D, De Fronzo RA. The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 1982;55:1648–1658.

    Google Scholar 

  42. Sherwin RS, Shulman GA, Hendler R, Walesky M, Belous A, Tamborlane WV. Effect of growth hormone on oral glucose tolerance and circulating metabolic fuels in man. Diabetologia 1983;24:155–161.

    Article  PubMed  CAS  Google Scholar 

  43. Donald RA. Plasma immunoreactive corticotrophin and cortisol response to insulin hypoglycemia in normal subjects and subjects with pituitary disease. J Clin Endocrinol Metab 1971;32:225–231.

    Article  PubMed  CAS  Google Scholar 

  44. Fish HR, Chernow B, O’Brian JT. Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia; a review. Metabolism 1986;35:763–780.

    Article  PubMed  CAS  Google Scholar 

  45. Baxter J, Forsham J. Tissue effects of glucocorticoids. Am J Med 1972;53:573–589.

    Article  PubMed  CAS  Google Scholar 

  46. DeFeo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, et al. Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 1989;257:E35–E42.

    CAS  Google Scholar 

  47. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined a- and β-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. J Clin Invest 1979;64:62–71.

    Article  PubMed  CAS  Google Scholar 

  48. DeFeo P, Perriello G, Torlone E, Ventura MM, Santeusanio F, Brunetti P, et al. Demonstration of a role for growth hormone in glucose counterregulation. Am J Physiol 1989;256:E835–E843.

    CAS  Google Scholar 

  49. Amiel SA, Simonson DC, Sherwin RS, Lauritano AA, Tamborlane WV. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. J Pediatr 1987;110:832–837.

    Article  PubMed  CAS  Google Scholar 

  50. Brambilla P, Bougneres PF, Santiago JV, Chaussin JL, Pouplard A, Castano L. Glucose counterregulation in pre-school-age children with recurrent hypoglycemia during conventional treatment. Diabetes 1987;36:300–304.

    Article  PubMed  CAS  Google Scholar 

  51. Singer-Granick C, Hoffman RP, Kerensky K, Drash AL, Becker DJ. Glucagon responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care 1988;11:643–649.

    Article  PubMed  CAS  Google Scholar 

  52. Hoffman RP, Singer-Granick C, Drash AL, Becker DJ. Plasma catecholamine responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care 1991;14:81–88.

    Article  PubMed  CAS  Google Scholar 

  53. Jones TW, Boulware SD, Kraemer DT, Caprio S, Sherwin RS, Tamborlane WV. Independent effects of youth and poor diabetes control on responses to hypoglycemia in children. Diabetes 1991;40:358–363.

    Article  PubMed  CAS  Google Scholar 

  54. Bjorgaas M, Vik T, Sand T, Birkeland K, Sager G, Vea H, et al. Counterregulatory and symptom responses to hypoglycaemia in diabetic children. Diabet Med 1997;14:433–441.

    Article  PubMed  CAS  Google Scholar 

  55. Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997;20:135–141.

    Article  PubMed  CAS  Google Scholar 

  56. Amiel SA, Maran A, Powrie JK, Umpleby AM, Macdonald IA. Gender differences in counterregulation to hypoglycaemia. Diabetologia 1993;36:460–464.

    Article  PubMed  CAS  Google Scholar 

  57. Evans M, Pernet A, Lomas J, Jones J, Amiel SA. Delay in onset of awareness of acute hypoglycemia and of restoration of cognitive performance during recovery. Diabetes Care 2000;23:893–897.

    Article  PubMed  CAS  Google Scholar 

  58. McCrimmon RJ, Gold AE, Deary IJ, Kelnar CJ, Frier BM. Symptoms of hypoglycemia in children with IDDM. Diabetes Care 1995;18:858–861.

    Article  PubMed  CAS  Google Scholar 

  59. Tupola S, Rajantie J. Documented symptomatic hypoglycaemia in children and adolescents using multiple daily injection therapy. Diabet Med 1998;15:492–496.

    Article  PubMed  CAS  Google Scholar 

  60. Amie! SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty: a contributor to poor diabetic control during adolescence. N Engl J Med 1986;315:215–219.

    Article  PubMed  CAS  Google Scholar 

  61. Dunger DB. Diabetes in puberty. Arch Dis Child 1992;67:569–570.

    Article  PubMed  CAS  Google Scholar 

  62. Daneman D, Frank M, Perlman K, Tamm J, Ehrlich R. Severe hypoglycemia in children with insulindependent diabetes mellitus: frequency and predisposing factors. J Pediatr 1989;5:681–685.

    Google Scholar 

  63. Davis EA, Keating B, Byrne GC, Russell M, Jones TW. Hypoglycemia: incidence and clinical predictors in a large population based sample of children and adolescents with IDDM. Diabetes Care 1997;20:20–25.

    CAS  Google Scholar 

  64. Shehadeh N, Kassem J, Tchaban I, Ravid S, Shahar E, Naveh T, et al. High incidence of hypoglycemic episodes with neurologic manifestations in children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998;11:183–187.

    PubMed  Google Scholar 

  65. Kerr D, Macdonald IA, Heller SR, Tattersall RB. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes. Diabetologia 1990;33: 216–221.

    Article  PubMed  CAS  Google Scholar 

  66. Richter EA. Glucose utilization. In: Rowell LB, Shepherd JT, eds. Exercise: Regulation and Integration of Multiple Systems. Oxford University Press, New York, 1996, pp. 912–951.

    Google Scholar 

  67. Holloszy JO, Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 1996;128:99–193.

    PubMed  CAS  Google Scholar 

  68. Ivy JL, Holloszy JO. Persistent increase in glucose uptake by rat skeletal muscle following exercise. Am J Physiol 1981;241:C200–C203.

    PubMed  CAS  Google Scholar 

  69. Cartee GD, Young DA, Sleeper MD, Zierath J, Wallberg-Henriksson H, Holloszy JO. Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol 1989;256:E494–E499.

    PubMed  CAS  Google Scholar 

  70. Mikines KJ, Sonne B, Farrell PA, Tronier B, Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. Am J Physiol 1988;254:E248–E259.

    PubMed  CAS  Google Scholar 

  71. Lawrence RD. The effects of exercise on insulin action in diabetes. Br Med J 1926;1:648–652.

    Article  PubMed  CAS  Google Scholar 

  72. George E, Marques JL, Harris ND, Macdonald IA, Hardisty CA, Heller SR. Preservation of physiological responses to hypoglycemia 2 days after antecedent hypoglycemia in patients with IDDM. Diabetes Care 1997;20:1293–1298.

    Article  PubMed  CAS  Google Scholar 

  73. Ovalle F, Fanelli CG, Paramore DS, Hershey T, Craft S, Cryer PE. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus. Diabetes 1998;47:1472–1479.

    Article  PubMed  CAS  Google Scholar 

  74. Davis SN, Shavers C, Mosqueda-Garcia R, Costa F. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans. Diabetes 1997;46:1328–1335.

    Article  PubMed  CAS  Google Scholar 

  75. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia 1995;38:1412–1418.

    Article  PubMed  CAS  Google Scholar 

  76. Fanelli CG, Epifano L, Rambotti AM, Pampenelli S, Vincenzo A, Modarelli F, et al. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine resposes to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 1993;42:1683–1689.

    Article  PubMed  CAS  Google Scholar 

  77. Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344:283–287.

    Article  PubMed  CAS  Google Scholar 

  78. Berlin I, Grimaldi A, Landault C, Zoghbi F, Thervet F, Puech AJ, et al. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients. J Clin Endocrinol Metab 1988;66:273–278.

    Article  PubMed  CAS  Google Scholar 

  79. Fritsche A, Stumvoll M, Grub M, Sieslack S, Renn W, Schmulling RM, et al. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects. Diabetes Care 1998;21:1505–1510.

    Article  PubMed  CAS  Google Scholar 

  80. Fritsche A, Stumvoll M, Haring HU, Gerich JE Reversal of hypoglycemia unawareness in a longterm type 1 diabetic patient by improvement of beta-adrenergic sensitivity after prevention of hypoglycemia. J Clin Endocrinol Metab 2000;85:523–525.

    Article  PubMed  CAS  Google Scholar 

  81. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest 1996;98:680–691.

    Article  PubMed  CAS  Google Scholar 

  82. Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995;333:1726–1731.

    Article  PubMed  CAS  Google Scholar 

  83. Lager I, Atvall S, Blohme G, Smith U. Altered recognition of hypoglycaemic symptoms in type 1 diabetes during intensified control with continuous subcutaneous insulin infusion. Diabet Med 1986;3:322–325.

    Article  PubMed  CAS  Google Scholar 

  84. Hwang J-H, Perseghin G, Rothman DL, Cline GW, Magnusson I, Petersen KF, et al. Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion. J Clin Invest 1995;95:783–787.

    Article  PubMed  CAS  Google Scholar 

  85. Cline GW, Rothman DL, Magnusson I, Katz LD, Shulman GI. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J Clin Invest 1994;94:2369–2376.

    Article  PubMed  CAS  Google Scholar 

  86. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunctti P, et al. Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning. Diabetologia 1990;33:52–59.

    Article  PubMed  CAS  Google Scholar 

  87. Matyka KA, Crowne EC, Havel PJ, Macdonald IA, Matthews D, Dunger DB. Counterregulation during spontaneous nocturnal hypoglycaemia in prepubertal children with insulin dependent diabetes mellitus. Diabetes Care 1999;22:1144–1150.

    Article  PubMed  CAS  Google Scholar 

  88. Fanelli CG, Pampanelli S, Porcellati F, et al. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial. Ann Intern Med 2002;136:504–514.

    Article  PubMed  CAS  Google Scholar 

  89. Bendtson I, Rosenfalck AM, Binder C. Nocturnal versus diurnal counterregulation to hypoglycemia in type 1 (insulin-dependent) diabetic patients. Acta Endocrinol 1993;128:109–115.

    PubMed  CAS  Google Scholar 

  90. Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med 1998;338:1657–1662.

    Article  PubMed  CAS  Google Scholar 

  91. Sawaya R, Ingvar DH. Cerebral blood flow and metabolism in sleep. Acta Neurol Scand 1989:80;481–491.

    Article  PubMed  CAS  Google Scholar 

  92. Maquet P, Dive D, Salmon E, Sadzot B, Franco G, Poirrier R, et al. Cerebral glucose utilization during the sleep-wake cycle in man determined by positron emission tomography and 18F-2-fluoro-2-deoxy-D-glucose method. Brain Res 1990;513:136–143.

    Article  PubMed  CAS  Google Scholar 

  93. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes 1993;42:1233–1237.

    Article  PubMed  CAS  Google Scholar 

  94. Boden G, Reichard GA, Hoeldtke RD, Rezvani I, Owen OE. Severe insulin induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med 1981;305:1200–1205.

    Article  PubMed  CAS  Google Scholar 

  95. Glazer RI, Weber G. Incorporation of [6-3H] glucose into lipid, protein, RNA and DNA slices of differentiating rat cerebral cortex. J Neurochem 1971;18:1569–1576.

    Article  PubMed  CAS  Google Scholar 

  96. Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Br Med J 1988;297:1304–1308.

    Article  CAS  Google Scholar 

  97. Anastasi A. Validity: basic concepts. In: Psychological Testing, 6th ed. Macmillan, New York. 1988, pp. 139–164.

    Google Scholar 

  98. Mitrakou A, Ryan C, Veneman T, Evron W, Jensen T, Cryer P, et al. Hierarchy of glycemic thresholds for activation of counterregulatory hormone secretion, initiation of symptoms and onset of cerebral dysfunction in normal humans. Am J Physiol 1991;260:E67–E74.

    PubMed  CAS  Google Scholar 

  99. Hoffman RG, Speelman DJ, Hinnen DA, Conley KL, Guthrie RA, Knapp RK. Changes in cortical functioning with acute hypoglycemia and hyperglycemia in type 1 diabetes. Diabetes Care 1989;12:193–197.

    Article  PubMed  CAS  Google Scholar 

  100. Widom B, Simonson DC. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1990;112:904–912.

    Article  PubMed  CAS  Google Scholar 

  101. Kerr D, Macdonald IA, Tatersall RB. Patients with type 1 diabetes adapt acutely to sustained mild hypoglycaemia. Diabet Med 1991;8:123–128.

    Article  PubMed  CAS  Google Scholar 

  102. Pramming S, Thorsteinsson B, Theilgaard A, Pinner EM, Binder C. Cognitive function during hypoglycaemia in type 1 diabetes mellitus. Br Med J 1986;292:647–650.

    Article  CAS  Google Scholar 

  103. Holmes CS, Koepke KM, Thompson RG. Simple versus complex performance impairments at three blood glucose levels. Psychoneuroendocrinology 1986;11:353–357.

    Article  PubMed  CAS  Google Scholar 

  104. Heller SR, Macdonald IA, Herbert M, Tattersall RB. Influence of sympathetic nervous system on hypoglycaemic warning symptoms. Lancet 1987;2:359–363.

    Article  PubMed  CAS  Google Scholar 

  105. Holmes CS. Metabolic control and auditory information processing at altered glucose levels in insulin-dependent diabetes. Brain Cogn 1987;6:161–174.

    Article  PubMed  CAS  Google Scholar 

  106. Blackman JD, Towle VL, Lewis GF, Spire J-P, Polonsky KS. Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes 1990;39:828–835.

    Article  PubMed  CAS  Google Scholar 

  107. Herold KC, Polonsky KS, Cohen RM, Levy J, Douglas F. Variable deterioration in cortical function during insulin induced hypoglycemia. Diabetes 1985;34:677–685.

    Article  PubMed  CAS  Google Scholar 

  108. Jones TW, Borg WP, Boulware SD, McCarthy G, Sherwin RS, Tamborlane WV. Enhanced adrenomedullary response and increased susceptibility to neuroglycopenia: mechanisms underlying the adverse effects of sugar ingestion in healthy children. J Pediatr 1995:126;171–177.

    Article  PubMed  CAS  Google Scholar 

  109. Bjorgaas M, Sand T, Vik T, Jorde R. Quantitative EEG during controlled hypoglycaemia in diabetic and non-diabetic children. Diabet Med 1998;15:30–37.

    Article  PubMed  CAS  Google Scholar 

  110. Bonnet MH. Effect of sleep disruption on sleep, performance, and mood. Sleep 1985;8:11–19.

    PubMed  CAS  Google Scholar 

  111. Stores G. Children’s sleep disorders: modern approaches, developmental effects, and children at special risk. Dev Med Child Neurol 1999;41:568–573.

    Article  PubMed  CAS  Google Scholar 

  112. Bendtson I, Gade J, Thomsen CE, Rosenfalck A, Wildschiodtz G. Sleep disturbances in IDDM patients with nocturnal hypoglycemia. Sleep 1992;15:74–81.

    PubMed  CAS  Google Scholar 

  113. Porter P, Byrne G, Stick S, Jones TW. Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus. Arch Dis Child 1996;75:120–123.

    Article  PubMed  CAS  Google Scholar 

  114. Matyka KA, Crawford C, Wiggs L, Dunger DB, Stores G. Alterations in sleep physiology in young children with insulin dependent diabetes mellitus: relationship to nocturnal hypoglycemia. J Pediatr 2000;137:233–238.

    Article  PubMed  CAS  Google Scholar 

  115. Bendtson I, Gade J, Theilgaard A, Binder C. Cognitive function in type 1 (insulin-dependent) diabetic patients after nocturnal hypoglycaemia. Diabetologia 1992;35:898–903.

    Article  PubMed  CAS  Google Scholar 

  116. King P, Kong M-F, Parkin H, Macdonald IA, Tatersall RB. Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM. Diabetes Care 1998;21:341–345.

    Article  PubMed  CAS  Google Scholar 

  117. Pocecco M, Ronfani L. Transient focal neurologic deficits associated with hypoglycaemia in children with insulin-dependent diabetes mellitus. Italian Collaborative Paediatric Diabetologic Group. Acta Paediatr 1998;87:542–544.

    Article  PubMed  CAS  Google Scholar 

  118. Perros P, Deary IJ, Sellar RJ, Best JJ, Frier BM. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 1997;20:1013–1018.

    Article  PubMed  CAS  Google Scholar 

  119. Wredling R, Levander S, Adamson U, Lins PE. Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 1990;33:152–157.

    Article  PubMed  CAS  Google Scholar 

  120. Langan SJ, Deary IJ, Hepburn DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 1991;34:337–344.

    Article  PubMed  CAS  Google Scholar 

  121. Ryan CM, Williams TM, Finegold DN, Orchard TJ. Cognitive dysfunction in adults with type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 1993;36:329–334.

    Article  PubMed  CAS  Google Scholar 

  122. Sachon C, Grimaldi A, Digy JP, Pillon B, Dubois B, Thervet F. Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Int Med 1992;231:471–475.

    Article  CAS  Google Scholar 

  123. Reichard P, Berglund A, Britz A, Levander S, Rosenquist U. Hypoglycaemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function. J Intern Med 1991;229:9–16.

    Article  PubMed  CAS  Google Scholar 

  124. The Diabetes Control and Complications Trial Research Group. Effects of intensive therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996;124:379–388.

    Article  Google Scholar 

  125. Austin EJ, Deary IJ. Effects of repeated hypoglycemia on cognitive function. Diabetes Care 1999;22:1273–1277.

    Article  PubMed  CAS  Google Scholar 

  126. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics 1985;75:921–927.

    PubMed  CAS  Google Scholar 

  127. Golden MP, Ingersoll GM, Brack CJ, Russell BA, Wright JC, Huberty TJ. Longitudinal relationship of asymptomatic hypoglycemia to cognitive function in IDDM. Diabetes Care 1989;12:89–93.

    Article  PubMed  CAS  Google Scholar 

  128. Bjorgraas M, Gimse R, Vik T, Sand T. Cognitive function in type 1 diabetic children with and without episodes of severe hypoglycaemia. Acta Paediatr 1997;86:148–153.

    Article  Google Scholar 

  129. Rovet J, Alvarez M. Attentional functioning in children and adolescents with IDDM. Diabetes Care 1997;20:803–810.

    Article  PubMed  CAS  Google Scholar 

  130. Northam EA, Anderson PJ, Werther GA, Warne GL, Andrewes D. Predictors of change in the neuropsychological profiles of children with type 1 diabetes 2 years after disease onset. Diabetes Care 1999;22:1438–1444.

    Article  PubMed  CAS  Google Scholar 

  131. Rovet JF, Ehrlich RM. The effect of hypoglycemic seizures on cognitive function in children with diabetes: a seven year prospective study. J Pediatr 1999;134:503–506.

    Article  PubMed  CAS  Google Scholar 

  132. Hershey T, Bhargava N, Sadler M, White NH, Craft S. Conventional versus intensive diabetes therapy in children with type 1 diabetes-effects on memory and motor speed. Diabetes Care 1999;22: 1318–1324.

    Article  PubMed  CAS  Google Scholar 

  133. Edge JA, Ford-Adams ME, Dunger DB. Causes of death in children with insulin dependent diabetes 1990–1996. Arch Dis Child 1999;81:318–323.

    Article  PubMed  CAS  Google Scholar 

  134. Sartor G, Dahlquist G. Short-term mortality in childhood onset insulin-dependent diabetes mellitus:a high frequency of unexpected deaths in bed. Diabet Med 1995;12:607–611.

    Article  PubMed  CAS  Google Scholar 

  135. Massin MM, Derkenne B, Tallsund M, Rocour-Brumioul D, Ernould C, Lebrethon M, et al. Cardiac autonomic dysfunction in diabetic children. Diabetes Care 1999;22:1845 – 1850.

    Article  PubMed  CAS  Google Scholar 

  136. Rollins MD, Jenkins JG, Carson DJ, McClure BG, Mitchell RH, Imam SZ. Power spectral analysis of the electrocardiogram in diabetic children. Diabetologia 1992;35:452–455.

    Article  PubMed  CAS  Google Scholar 

  137. Singh N, Mironov D, Armstrong PW, Ross AM, Langer A. Heart rate assessment early after acute myocardial infarction. Circulation 1996;93:1388–1395.

    Article  PubMed  CAS  Google Scholar 

  138. Weston PJ, Gill GV. Is undetected autonomic dysfunction responsible for sudden death in type 1 diabetes mellitus? The “dead in bed” syndrome revisited. Diabet Med 1999;16:626–631.

    Article  PubMed  CAS  Google Scholar 

  139. Gold AE, Deary IJ, Frier BM. Hypoglycaemia and non-cognitive aspects of psychological function in insulin-dependent (type 1) diabetes mellitus (IDDM). Diabet Med 1997;14:111–118.

    Article  PubMed  CAS  Google Scholar 

  140. Clarke WL, Gonder-Frederick A, Snyder AL, Cox DJ. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab 1998;11:189–194.

    Article  PubMed  Google Scholar 

  141. Gonder-Frederick L, Cox D, Kovatchev B, Julian D, Clarke W. The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM. Diabetes Care 1997;20:1543–1546.

    Article  PubMed  CAS  Google Scholar 

  142. Marrero DG, Guare JC, Vandagriff JL, Fineberg NS. Fear of hypoglycemia in the parents of children and adolescents with diabetes: maladaptive or healthy response? Diabetes Educ 1997;23:281–286.

    Article  PubMed  CAS  Google Scholar 

  143. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.

    Article  Google Scholar 

  144. Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care. 1995;18:523–528.

    Article  PubMed  CAS  Google Scholar 

  145. Jorgens V, Grusser M, Bott U, Muhlhauser I, Berger M. Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia 1993;36:99–105.

    Article  PubMed  CAS  Google Scholar 

  146. Orre-Pettersson AC, Lindstrom T, Bergmark V, Arnqvist HJ. The snack is critical for the blood glucose profile during treatment with regular insulin preprandially. J Intern Med 1999;245:41–45.

    Article  PubMed  CAS  Google Scholar 

  147. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779–1784.

    Article  PubMed  CAS  Google Scholar 

  148. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care 1996;19:324–327.

    Article  PubMed  CAS  Google Scholar 

  149. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230–238.

    Article  PubMed  CAS  Google Scholar 

  150. Kaufman FR, Halvorson M, Kaufman ND. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995;30:205–209.

    Article  PubMed  CAS  Google Scholar 

  151. Detlofson I, Kroon M, Aman J. Oral bedtime cornstarch supplementation reduces the risk for nocturnal hypoglycaemia in young children with type 1 diabetes. Acta Paediatr 1999;88:595–597.

    Article  PubMed  CAS  Google Scholar 

  152. Axelsen M, Wesslau C, Lonnroth P, Arvidsson Lenner R, Smith U. Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycemia in intensively treated type 1 diabetes subjects. J Intern Med 1999;245:229–236.

    Article  PubMed  CAS  Google Scholar 

  153. Ververs MT, Rouwe C, Smit GP. Complex carbohydrates in the prevention of nocturnal hypoglycaemia in diabetic children. Eur J Clin Nutr 1993;47:268–273.

    PubMed  CAS  Google Scholar 

  154. Buyken AE, Toeller M, Heitkamp G, Vitelli F, Stehle P, Scherbaum WA, et al. Relation of fibre intake to HbA 1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group. Diabetologia 1998;41:882–890.

    Article  PubMed  CAS  Google Scholar 

  155. McCulloch DK, Kutrz AB, Tattersall RB. A new approach to the treatment of nocturnal hypoglycemia using alpha-glucosidase inhibition. Diabetes Care 1983;6:483–487.

    Article  PubMed  CAS  Google Scholar 

  156. Kanc K, Janssen MM, Keulen ET, Jacobs MA, Popp-Snijders C, Snoek FJ, et al. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Diabetologia 1998;41:322–329.

    Article  PubMed  CAS  Google Scholar 

  157. Kaufman FR, Halvorson MJ, Kim C. Use of insulin pump therapy at night only for pre-teen children with type 1 diabetes. Diabetes 1999;48:Al2.

    Google Scholar 

  158. Ahmed AB, Home PD. The effect of the insulin analog lispro on night-time blood glucose control in type 1 diabetic patients. Diabetes Care 1998;21:32–37.

    Article  PubMed  CAS  Google Scholar 

  159. Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 1999;22:1607–1611.

    Article  PubMed  CAS  Google Scholar 

  160. Mohn A, Matyka KA, Harris DA, Ross KM, Edge JA, Dunger DB. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Diabetes Care 1999;22:27–32.

    Article  PubMed  CAS  Google Scholar 

  161. Rosskamp RH, Park G. Long-acting insulin analogs. Diabetes Care 1999;22:B109–B113.

    PubMed  Google Scholar 

Download references

Authors
  1. Stephanie A. Amiel BSc, MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krystyna Matyka MRCP, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Mark A. Sperling MD (Professor of Pediatrics and Chair Emeritus) (Professor of Pediatrics and Chair Emeritus)

  2. Division of Endocrinology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA

    Mark A. Sperling MD (Professor of Pediatrics and Chair Emeritus) (Professor of Pediatrics and Chair Emeritus)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Amiel, S.A., Matyka, K. (2003). Hypoglycemia in Type 1 Diabetes. In: Sperling, M.A. (eds) Type 1 Diabetes. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-310-1_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-310-1_18

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-258-2

  • Online ISBN: 978-1-59259-310-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation